Interpace Biosciences (IDXG) Net Income

Price: $2.005
Market Cap: $8.83M
Avg Volume: 7.93K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 0.669
52W Range: $1.01-2.08
Website: Interpace Biosciences

What is Interpace Biosciences's Net Income?

  • Interpace Biosciences's annual net income as of FY 2023 is $802.00K.
  • Interpace Biosciences's quarterly net income as of Q2 2024 is $2.06M.

What is Net Income?

Net income is the total profit of a company after all expenses and taxes have been deducted from revenue. It is also known as net profit or net earnings and is a key indicator of a company's financial performance and profitability.

Related Metrics

Other important metrics to assess Interpace Biosciences's financial health include:

  • Net Income Growth - the rate at which a company's net income is growing:
    • Annual Growth: 113.67%
  • Net Income Ratio - net income divided by revenue:
    • Annual: 1.99%
    • Quarterly: 17.12%
  • Net Income Per Share - net income divided by the number of shares outstanding:
    • Annual: $0.19

These metrics provide insights into Interpace Biosciences's financial health and its profitability. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Net Income

$802.00K

Quarterly Net Income

$2.06M

Historical Annual Net Income
Historical Quarterly Net Income
Annual Net Income Growth
Annual Net Income Per Share

Interpace Biosciences Historical Net Income Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.

Year Net Income Net Income Growth Net Income Ratio Net Income Per Share
2023 $802.00K 113.67% 1.99% $0.19
2022 $-5.87M 60.23% -18.42% $-1.38
2021 $-14.75M 43.72% -35.69% $-3.57
2020 $-26.20M 1.64% -80.87% $-6.50
2019 $-26.64M -118.55% -110.63% $-7.11
2018 $-12.19M 0.22% -55.67% $-4.33
2017 $-12.22M -46.62% -76.84% $-7.77
2016 $-8.33M 26.63% -63.68% $-45.88
2015 $-11.36M 29.35% -120.40% $-73.38
2014 $-16.07M -252.09% -13.40% $-107.87